Percentage of lung cytopathology or pathology specimen cases with non-small cell lung carcinoma (NSCLC) that address presence or absence of actionable targets through ancillary biomarker testing AND meet the maximum 10 day turnaround time (TAT) requirement (Report Date of ancillary biomarker testing – Accession Date = ≤ 10 days). This measure has two performance rates that contribute to the overall performance score: 1. Percent of cases in which ancillary biomarker testing for actionable targets with a diagnosis of non-small cell carcinoma is addressed. 2. Percent of cases that meet the maximum 10 day turnaround time. The overall performance score submitted is a weighted average of: (Numerator 1 + Numerator 2)/(Denominator)